Major Revenue Gains are Predicted in the Global Empty Capsules Market by 2026

Overview of This Study:  This research study on Empty Capsules involved the use of widespread secondary sources; directories; databases such as D&B, Bloomberg Business, and Factiva; white papers; annual reports; and Companies’ House documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global empty...

Drug Discovery Informatics System : Control Drug Discovery and Development Costs

Growth of the global market include the rising R&D expenditure, the increasing focus on drug discovery, and need to control the drug discovery and development cost. On the other hand, the scarcity of skilled professionals, and high pricing and setup cost of informatics software are the major factors restraining the growth of this market. The drug discovery informatics market is segmented on the...

Increasing Purity Requirements in Pharma and Biotechnology Industries Demanding Track etched Membrane Market

The track etched membrane market is expected to reach USD 813.1 million by 2023 from USD 476.0 million in 2018, at a CAGR of 11.3% from 2018 to 2023. The key factors driving the growth of this market include increasing R&D spending in the pharmaceutical and biopharmaceutical industries and increasing purity requirements among end users of track etched membranes. However, the high cost of production...

“Bioprinting human organs” to be the future demand in 3D Printing Market

The global 3D bioprinting market is expected to reach USD 1,332.6 million in 2021 from USD 411.4 million, at a CAGR of 26.5% from 2016 to 2021. The 3D bioprinting market is primarily driven by the rising demand for organ transplantation, alongside the growth in R&D activity and public & private investments for research and the rising use of 3D bioprinting in drug discovery. Download FREE Brochure...

Cancer Diagnostics to Dominate the Next-Generation Sequencing Diagnostic Applications Market Till 2024

The global next-generation sequencing market is projected to reach USD 16.35 billion by 2024 from USD 5.70 billion in 2018, at a CAGR of 19.2%. Factors such as advancements in NGS platforms, declining NGS capital cost coupled with the decreasing cost of sequencing, and improving regulatory & reimbursement scenario for NGS-based diagnostic tests are driving the growth of the global NGS market. However,...

Global Opportunities and Trends of Microcarrier Market

The global microcarriers market is expected to reach USD 1.61 billion by 2023 from USD 1.20 billion in 2018, at a CAGR of 6.0%. Growth in this market is driven by the rising demand for cell-based vaccines, technological advancements, and the availability of public and private funding for cell-based research. Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=139831731 Based...

Technological Advancements in Disease Diagnostics Driving Microbiology Testing/Clinical Microbiology Market

The clinical microbiology market is projected to register a CAGR of 6.4%, growing from USD 3.63 billion in 2018 to USD 4.95 billion in 2023. Growth in clinical microbiology market can be attributed to factors such as rising incidence of infectious diseases and growing outbreak of epidemics and increased funding and public-private investments. Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=219135367 The...

Transfer Membrane Market | Projected to Reach USD 187.9 Million |At a CAGR of 1.5% |Global Forecast to 2023

The global transfer membrane market is projected to reach 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5%. Factors such as increasing public and private funding for life science research, high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies  are expected to drive the growth of this market. However,...

Nuclear Medicine/Radiopharmaceuticals Market is is projected to expand at a healthy CAGR of 5.9% by 2023

The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from an estimated USD 3.95 billion in 2018, at a CAGR of 5.9%. Growth in this market is mainly driven by factors such as the increasing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. Moreover, the use of radiopharmaceuticals in novel neurological applications...

Increasing Incidence of Blood Disorders and Integration of Hematology Analyzers With Flow Cytometry Driving Hematology Analyzers and Reagents Market

The global hematology products market is projected to reach USD 4.98 billion by 2023 from USD 3.31 billion in 2018, at a CAGR of 8.5%. The growth in blood donation and the increasing incidence of blood disorders are the major factors driving the growth of the global hematology analyzers and reagents market. Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=153222146 In this...